Scandinavian ChemoTech achieves clinical success within the subsidiary Vetiqure AB
After the treating veterinarian at Evidensia Specialist Animal Hospital Helsingborg carried out the last follow-up of the dog that was treated in the autumn of 2021, a very good clinical result can be confirmed.During the late summer, the Company's subsidiary within Animal Care began a collaboration with Evidensia Specialist Animal Hospital Helsingborg, where vetIQure™ with its Tumour Specific Electroporation technology (TSE) is currently being evaluated on both small animals and horses. “A dog with a giant cell tumour in the palate has been treated with a positive outcome. It was a very